Commercial seaweed is edible type of algae which have a rich source of vitamins and minerals. They are used in various products like food, personal care, healthcare product, etc. The market is expected to grow due to the growing demand for seaweed-based food products is increasing. Increasing application of Commercial seaweed in pharmaceutical sector is further anticipated to propel the market in the coming years. Growing demand for organic foods is also expected to drive the market growth. Moreover, the seaweed extracts like carrageenan, alignate and agar are gaining popularity which is also expected to fuel the market. The market is segmented into type, form, application and geography. Basis of type, the red seaweed is expected to hold a significant share in the market owing its wide consumption in food, pharmaceutical and cosmetics. Geographically, Asia Pacific is projected to be a substantial shareholder in market during the forecasted period due to its large production and domestic consumption in countries like China and Japan. North America is estimated to grow during the forecasted period as growing R&D activities, increasing awareness about its nutritive value and adoption of seaweed in various industries.
Increasing application of seaweed in various industries.
Growing demand of edible seaweed.
Growing R&D activates.
Seaweed emerging as a snack.
In January 2019, England proposes first commercial seaweed farm between the coast of Shoreham and Elmer.
The major players profiled in the Commercial Seaweed market are Biostadt India, Roullier Group, CEAMSA, Seasol International, CP Kelco, Cargill, Seawin Biotech, COMPO Expert, Algea, Algaia, Gleymar, BRANDT, Acadian Seaplant and DoDowPont
The Commercial Seaweed market been analyzed through the following segments:
Food and Beverage
Middle East and Africa